Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2012-01-31 | Seth W. Hamot was elected as a director in December 2011... The following table sets forth certain information regarding each of the remaining directors... Seth W. Hamot, 49, Director, Director Since 2011... Nominating / Corporate Governance Committee... Mr. Hamot joined our Board of Directors in fiscal 2012 and thus, during fiscal 2011, did not earn any compensation for services on our Board of Directors. |
| Filing Date | Source Excerpt |
|---|---|
| 2007-10-26 | Seth W. Hamot 45 Managing Member, Roark, Rearden & Hamot Capital Management, LLC (RRHCM), and owner of Roark, Rearden & Hamot, Inc. (RRHI), since 1997, and President of Roark, Rearden & Hamot, LLC (RRH) since 2002. Mr. Hamot has been a director of the Company since June 18, 2007. Mr. Hamot is currently the Interim Non-executive Chairman of the Board of Bradley Pharmaceuticals Inc., a NYSE listed specialty pharmaceutical company, and serves as a member of that company’s audit committee. Mr. Hamot is also a Director of CCA Industries, Inc., an AMEX listed manufacturer of health and beauty aids, and serves as a member of the audit and compensation committees. |
| 2009-10-27 | Seth W. Hamot, 47, Managing Member, Roark, Rearden & Hamot Capital Management, LLC, and owner of Roark, Rearden & Hamot, Inc., since 1997. Mr. Hamot has been a director of the Company since June 18, 2007. |
| 2010-10-15 | Seth W. Hamot Age 48 Managing Member, Roark, Rearden & Hamot Capital Management, LLC (RRHCM), and owner of Roark, Rearden & Hamot, Inc. (RRHI), since 1997, and President of Roark, Rearden & Hamot, LLC (RRH) since 2002. Mr. Hamot has been a director of the Company since June 18, 2007. Mr. Hamot was nominated for election by Costa Brava Partnership III L.P. (Costa Brava), an investment fund and a holder of the Company's Public Preferred Stock. Since 1997, Mr. Hamot has been the Managing Member of RRHCM and the owner of RRHI, the corporate predecessor of RRHCM. RRHCM is the investment manager to Costa Brava, whose principal business is to make investments in, buy, sell, hold, pledge and assign securities. Mr. Hamot is also the President of RRH, the general partner of Costa Brava. Prior to 1997, Mr. Hamot was one of the partners of the Actionvest entities. Mr. Hamot is presently a director of Orange 21, Inc. and chairman of TechTeam Global, Inc., both NASDAQ companies. Mr. Hamot was elected pursuant to the Company's governing documents by the holders of the Company's 12% Cumulative Exchangeable Redeemable Preferred Stock and his election is not subject to any recommendations for election by the Board. |
| 2012-04-23 | Seth W. Hamot was elected pursuant to the Company’s governing documents by the holders of the Public Preferred Stock and his election is not subject to any recommendations for election by the Board. He received no compensation as a director in 2011. |
| 2014-04-22 | Seth W. Hamot, 52, Managing Member, Roark, Rearden & Hamot Capital Management, LLC (“RRHCM”), and owner of Roark, Rearden & Hamot, Inc. (“RRHI”), since 1997, and President of Roark, Rearden & Hamot, LLC (“RRH”) since 2002. RRH is a general partner of, and RRHCM is the investment manager to, Costa Brava Partnership III L.P. (“Costa Brava”), whose principal business is to make investments in, buy, sell, hold, pledge and assign securities. Mr. Hamot has been a director of the Company since June 18, 2007. Mr. Hamot was nominated for election by Costa Brava, a holder of the Public Preferred Stock. Mr. Hamot is presently also the chairman of Spy, Inc. (NASDAQ: Spy), an eyewear company, and a director of Piksel, Inc. Previously, he served as chairman of TechTeam Global, Inc. and Bradley Pharmaceutical, Inc. Mr. Hamot was elected pursuant to the Company’s governing documents by the holders of the Public Preferred Stock and his election is not subject to any recommendations for election by the Board. Director Compensation for 2013: None. |
| 2017-04-17 | Seth W. Hamot, 55, Managing Member, Roark, Rearden & Hamot Capital Management, LLC ("RRHCM"), and owner of Roark, Rearden & Hamot, Inc. ("RRHI"), since 1997, and President of Roark, Rearden & Hamot, LLC ("RRH") since 2002. Mr. Hamot has been a director of the Company since June 18, 2007. The following table summarizes the director compensation paid during the year ended December 31, 2016: Seth W. Hamot, Total: $0. |
Data sourced from SEC filings. Last updated: 2025-08-30